Skip to content

Clinical trials

Observational Scleroderma, Systemic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Observational Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20052
20073
20083
20091
20131
20141
20161
20171
20181
20201
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting4
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University3
Louisiana State University Health Sciences Center in New Orleans2
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2
University of Michigan2
Yale University2
Actelion1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
George Washington University1
Georgetown University1
Kyverna Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic22
Scleroderma, Diffuse8
Dermatomyositis5
Arthritis, Rheumatoid4
Hypertension, Pulmonary4
Lupus Erythematosus, Systemic4
Mixed Connective Tissue Disease4
Autoimmune Diseases3
Connective Tissue Diseases3
Multiple Sclerosis3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.